Literature DB >> 3282648

Oligodeoxynucleotides as inhibitors of gene expression: a review.

C A Stein1, J S Cohen.   

Abstract

The past several years have seen an explosive growth in the application of antisense oligodeoxynucleotides as modulators of gene expression. In this review, we discuss the various classes of compounds currently receiving attention. These include unmodified oligodeoxynucleotides, methylphosphonates, phosphorothioates, and alpha-oligonucleotides. The relative advantages and disadvantages of each class with regard to parameters such as (a) duplex stability (b) nuclease resistance, and (c) effectiveness of specific gene inhibition are noted. Oligodeoxynucleotides covalently linked to intercalating and other reactive groups are also described, as are possible mechanisms of oligodeoxynucleotide action. Finally, we consider potential future directions for this field and note that it holds the promise for specific gene therapy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3282648

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  73 in total

1.  Hybrid characteristics of oligonucleotides consisting of isonucleoside 2',5'-anhydro-3'-deoxy-3'-(thymin-1-yl)-D-mannitol with different linkage modes.

Authors:  Z Lei; L Zhang; L R Zhang; J Chen; J M Min; L H Zhang
Journal:  Nucleic Acids Res       Date:  2001-04-01       Impact factor: 16.971

Review 2.  Preclinical and clinical pharmacology of antisense oligonucleotides.

Authors:  E G Marcusson; B R Yacyshyn; W R Shanahan; N M Dean
Journal:  Mol Biotechnol       Date:  1999-08       Impact factor: 2.695

3.  Efficient cationic lipid-mediated delivery of antisense oligonucleotides into eukaryotic cells: down-regulation of the corticotropin-releasing factor receptor.

Authors:  F Shi; A Nomden; V Oberle; J B Engberts; D Hoekstra
Journal:  Nucleic Acids Res       Date:  2001-05-15       Impact factor: 16.971

4.  A1 receptor and adenosinergic homeostatic regulation of sleep-wakefulness: effects of antisense to the A1 receptor in the cholinergic basal forebrain.

Authors:  Mahesh M Thakkar; Stuart Winston; Robert W McCarley
Journal:  J Neurosci       Date:  2003-05-15       Impact factor: 6.167

5.  A human telomerase-associated nuclease.

Authors:  Rena Oulton; Lea Harrington
Journal:  Mol Biol Cell       Date:  2004-04-30       Impact factor: 4.138

6.  Antiproliferative effects of a c-myc antisense oligonucleotide on human arterial smooth muscle cells.

Authors:  M Ebbecke; C Unterberg; A Buchwald; S Stöhr; V Wiegand
Journal:  Basic Res Cardiol       Date:  1992 Nov-Dec       Impact factor: 17.165

7.  Manipulations of cholinesterase gene expression modulate murine megakaryocytopoiesis in vitro.

Authors:  D Patinkin; S Seidman; F Eckstein; F Benseler; H Zakut; H Soreq
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

8.  Synthesis of well-defined phosphate-methylated DNA fragments: the application of potassium carbonate in methanol as deprotecting reagent.

Authors:  W H Kuijpers; J Huskens; L H Koole; C A van Boeckel
Journal:  Nucleic Acids Res       Date:  1990-09-11       Impact factor: 16.971

9.  Depletion of O6-alkylguanine-DNA alkyltransferase activity in mammalian tissues and human tumor xenografts in nude mice by treatment with O6-methylguanine.

Authors:  M E Dolan; G L Larkin; H F English; A E Pegg
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

10.  Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia.

Authors:  R Morishita; G H Gibbons; K E Ellison; M Nakajima; L Zhang; Y Kaneda; T Ogihara; V J Dzau
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.